Globus Medical (GMED) Shares Outstanding (2011 - 2026)

Globus Medical (GMED) has reported Shares Outstanding (Entity) for 16 consecutive years, with $134.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Shares Outstanding (Entity) fell 0.59% year-over-year to $134.3 million; the trailing twelve-month figure through Jun 2026 stood at $134.3 million (down 0.59% YoY), and the FY2025 full-year result was $135.3 million, down 1.66% from the prior year.
• Shares Outstanding (Entity) declined to $134.3 million in Q2 2026 per GMED's latest filing, from $135.7 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $140.6 million in Q3 2023 and bottomed at $99.5 million in Q2 2022.
• Historically, Shares Outstanding (Entity) has averaged $124.0 million across 5 years, with a median of $135.1 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Entity) jumped 40.82% in 2023, then slipped 3.15% in 2024.
• Over 5 years, Shares Outstanding (Entity) stood at $100.3 million in 2022, then soared by 34.96% to $135.4 million in 2023, then increased by 1.6% to $137.5 million in 2024, then dropped by 1.66% to $135.3 million in 2025, then slipped by 0.73% to $134.3 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $134.3 million, $135.7 million, and $135.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.